[P3] B

[P3-086-B] Therapeutic use of aminoglycosides for Escherichia coli and Salmonella spp. infection treatment in the era of prudent use concepts

*Ulrich KLEIN¹, Lieven Claerhout¹, Wouter Depondt¹ (1. Huvepharma NV (Belgium))

Keywords:

Aminoglycosides,Escherichia coli,Salmonella spp.,Apravet apramycin pharmacokinetics